Presentation at Jefferies Healthcare Conference
hVIVO plc will present at the Jefferies Global Healthcare Conference in London on November 20, 2025, at 12:30 pm GMT. The conference, held from November 17-20, is expected to host over 700 healthcare companies and 3,600 attendees, facilitating 10,000 investor and business-to-business meetings. The presentation material will be available on the company's website shortly after the event. No new material information will be disclosed during the presentation.
Select text to share a quote on X · sign in to keep highlights & notes in your HVO notes
hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that Yamin 'Mo' Khan, Chief Executive Officer, will be presenting in-person at the Jefferies Global Healthcare Conference in London on 20 November 2025 at 12.30pm GMT. Alongside the presentation, the Company will also be available for one-to-one meetings.
The Jefferies Global Healthcare Conference is the largest healthcare-dedicated conference in Europe and is taking place between the 17-20 November 2025 in London. The conference hosts over 700 healthcare companies, 3,600 attendees, and 10,000 investor and business-to-business meetings. The event brings together C-suite executives from leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia.
No new material information will be disclosed during the day and the PDF of the presentation will be made available on the Company's website shortly after the event.
| P eel Hunt L LP (Joint Broker) | +44 (0)20 7418 8900 |
| James Steel, Dr Christopher Golden | |
| Davy (Joint Broker) | +353 (0) 1 679 6363 |
| Anthony Farrell, Niall Gilchrist | |
| Walbrook PR (Financial PR & IR) Paul McManus / Alice Woodings / Lianne Applegarth | +44 (0) 20 7933 8780 or hvivo@walbrookpr.com +44 (0)7980 541 893 / +44 (0)7407 804 654/ +44 (0)7584 391 303 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.